Covidien discloses details of the pending $43 billion acquisition by Medtronic, including who approached who and what Covidien chief Jose Almeida will do after handing the reins to Medtronic.
Democrats in the Senate and House push a measure to withhold federal contracts from companies that move their headquarters overseas to find better corporate tax rates.
A handful of Democrats in Congress are hoping to curb a corporate exodus by threatening to withhold federal contracts from firms that shift their headquarters overseas to benefit from lower tax rates.
The chiefs of Medtronic and Covidien hit the road to visit a slew of company sites and talk business as the medtech titans prepare to merge.
Medtronic's Omar Ishrak testing devices with with Gene Stellon, R&D VP at Covidien.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
President Barack Obama condemns corporate inversions, like the one Medtronic's planning in its mega-merger with Covidien, saying that companies are "renouncing their citizenship" in order to dodge taxes.
MASSDEVICE ON CALL — President Barack Obama took time in this weeks' regular address to criticize the wave of "corporate inversions," in which companies, such as Medtronic (NYSE:MDT), are using outside-U.S. acquisitions to shift their headquarters overseas.
Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.
The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.
Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtronic shareholder sues to block Covidien merger; Medtronic pays up to $105 million for Visualase; Elekta eyes Turkish radiology market with acquisition of Mesi Medikal; Ulthera pulls $86M IPO in favor of $600M merger